Exploring the Antidiabetic Efficacy of Radermachera xylocarpa (Roxb.) Fruit Extract through In vitro Study
Pratik Terse*, Shraddha Deshpande, Pranali Dharne, Siddhi Masurkar,
Rutuja Samant, Neha Sutar
Shree Pushpasen Sawant College of Pharmacy, Digas, Kudal, Pin - 416521, Maharashtra, India.
*Corresponding Author E-mail: spscobp03@gmail.com
ABSTRACT:
The current study investigates the antidiabetic potential of Radermachera xylocarpa (Roxb.) fruit extract through in-vitro α-amylase inhibition assay, validating its traditional use for blood sugar control. The fruits were collected from Sindhudurg region, shade dried, grounded, and extracted using ethanol. Preliminary phytochemical study showed the presence of alkaloids, phenols, steroids, terpenoids, lapachol, isoquercitrin, and naphthaquinones compounds commonly associated with antidiabetic and antioxidant properties. The α-amylase inhibition assay demonstrated dose-dependent enzyme inhibition, ranging from 16.09% to 57.47% for extract concentrations of 20–100 µg/mL, compared to 18.39% to 84.48% for the standard drug Acarbose. Although less potent than the standard, the extract showed moderate inhibitory activity, indicating its ability to slow starch breakdown and reduce postprandial hyperglycemia. This study provides initial scientific evidence supporting the traditional claims of R. xylocarpa fruit in diabetes management and highlights its potential as a natural source for future antidiabetic formulations. Further work including formulation development, toxicity studies, and in vivo evaluation is recommended.
KEYWORDS: Anti diabetic, Radermachera xylocarpa, α-amylase, In vitro, Phytoconstituents.
INTRODUCTION:
Diabetes mellitus, commonly mentioned as diabetes, is a group of chronic metabolic disorders characterized by persistently high blood sugar levels known as hyperglycemia over a prolonged period. This condition arises from defects in insulin secretion, insulin action, or both, leading to disturbances in carbohydrate, protein, and fat metabolism. The elevated blood sugar typically reveals through classic symptoms such as polyuria (frequent urination), polydipsia (increased thirst), and polyphagia (increased hunger) Other common symptoms include weight loss, blurred vision, weakness, and fatigue. If left untreated or poorly managed, diabetes can lead to severe complications. Acute, life-threatening complications include diabetic ketoacidosis and hyperosmolar hyperglycemic state.1
Types of Diabetes:
1. Type 1:
· Type 1 DM is due to an absolute absence of insulin and has an autoimmune basis. ß-cell destruction with little or no endogenous
2. Type 2:
· Ranges from relative Insulin deficiency to Disorders of Insulin secretion and Insulin resistance.
3. Other specific types:
· Genetic defects of ß-cell function
· Genetic defects in insulin secretion
· Diseases of the exocrine pancreas Endocrinopathies.
· Chemical induced Infections
· Uncommon forms of immune-mediated diabetes.
· Other genetic syndromes
· Gestational diabetes 2
Diabetes Mellitus Worldwide:1
Diabetes mellitus has reached pandemic proportions, influence both developed and developing nations globally. In 2000, an estimated 175 million individuals worldwide, a figure projected to nearly double to 354 million by 2030 This growth is particularly pronounced in developing regions, including the Middle Eastern Crescent, Sub-Saharan Africa, and the Indian subcontinent, which are expected to host over 85 percent of the world's diabetic population by 2030. In India alone, the occurrence of diabetes is anticipated to surge from 31.7 million in 2000 to an estimated 79.4 million by 2030. It is crucial to note that these projections might even be conservative, as they assume a stable incidence of obesity. Given the alarming increase in obesity rates across both developed and developing countries, the actual number of individuals affected by diabetes could significantly exceed this existing evaluation.3
Indian Scenario:
In the Indian situation, the challenge of diabetes is particularly severe. A national inspection conducted in six considerable cities in the India in 2000 indicated that the frequency of diabetes among urban Indian adults was 12.1%. Alarmingly, the onset of diabetes among Indians tends to be about a decade prior than their western counterparts, a trend consistently noted in studies involving Asian Indians. This earlier onset means that over half (54.1%) of diabetic patients in India develop the condition during their most productive years, before the age of 50, which also correlates with a higher risk of developing chronic complications. Furthermore, the prevalence of Type 2 diabetes is significantly higher in urban areas of India, approximately 4-6 times greater than in rural areas. Even in rural populations, the incidence of impaired glucose tolerance is substantial, ranging from 7-8%, suggesting a strong genetic predisposition for Type 2 diabetes within the ethnic Indian population.3
Fig No. 1 Age wise Percent Distribution of Men and Women Indian Scenario
Treatment for Diabetes mellitus:
Insulin Therapy:
Insulin remains the central pillar of diabetes management, particularly for patients with Type I diabetes mellitus and for those with advanced Type II diabetes who fail to respond to oral medication. The primary goal of insulin therapy is to replicate physiological insulin secretion patterns, thereby limiting postprandial hyperglycemia and preventing hypoglycemia during fasting condition. The route and site of administration play a crucial role in ensuring safe and effective insulin action, with intramuscular and intravenous routes being commonly preferred. Human, bovine, and porcine insulin preparations are available in market to treat diabetes mellitus.4
Disadvantages:
Despite its efficacy, insulin therapy is linked with certain drawbacks. The most renowned adverse effects include weight gain and hypoglycemia, often resulting from inappropriate dosing or mismatched timing between meals and insulin administration. Weight gain following insulin initiation is largely attributed to increased fat deposition and enhanced energy utilization due to reduced glycosuria. These side effects underscore the need for alternative or adjunctive therapies that offer enhanced safety and patient compliance.4
Oral Hypoglycemic Agents:
Oral hypoglycemic drugs, like sulfonylureas (e.g. glipizide) and biguanides (e.g., metformin), are broadly prescribed for Type II diabetes mellitus. Sulfonylureas act by exciting pancreatic β-cells to release insulin, while biguanides primarily enhance peripheral glucose uptake and prevent hepatic gluconeogenesis.4
Disadvantages:
The prolonged use of oral hypoglycemics is limited by various adverse effects, including gastrointestinal disturbances, weight gain, and the risk of lactic acidosis (particularly with biguanides). Additionally, these agents may show reduced efficacy over time, leading to treatment failure. The requirement for multiple medications, increased cost, and potential drug–drug interactions further complicate their therapeutic application.4
Herbal and Phytomedicinal Approaches:
Given the drawbacks of synthetic antidiabetic agents, there has been growing attention in the use of medicinal plants as alternative or complementary therapies for diabetes management. Countless plant species possess bioactive compounds with hypoglycemic, antioxidant, and insulin-sensitizing properties.
· Acacia Arabica (Babhul): Widely distributed across India, the extract acts as an insulin secretagogue, increasing endogenous insulin release.
· Aegle marmelos (Bel or Bilva): Aqueous leaf extracts improve digestion, decrease blood glucose, serum cholesterol, and urea levels, and prevent peak postprandial glucose rise in oral glucose tolerance tests.
· Allium cepa (Onion): Ether-soluble and insoluble fractions of onion powder demonstrate significant antihyperglycemic effects.
· Allium sativum (Garlic): Containing the sulfur compound allicin, garlic show potent hypoglycemic activity attributed to enhanced hepatic glucose metabolism, increased insulin secretion, and insulin-sparing effects.
· Azadirachta Indica (Neem): Hydroalcoholic extracts show remarkable antihyperglycemic, antibacterial, antimalarial, hepatoprotective, and antioxidant properties.
· Caesalpinia Bonducella: usually used by tribal communities for blood sugar regulation, both aqueous and ethanolic extracts have shown strong hypoglycemic activity in chronic Type II diabetes models.5
Bignoniaceae family of Radermachera Xylocarpa is a species of flowering plant. It is recognizable as a rare indigenous forest tree type. This plant is primarily used for its wood and is also noted for possessing general medicinal properties. Its specific habitat requirements and overexploitation have controlled its distribution to limited areas.6
Significantly, traditional knowledge among certain tribal section in the Jawhar and Shahapur Forest Divisions shows a specific therapeutic application for Radermachera xylocarpa fruit. Radermachera xylocarpa, locally known as "Kharshingi," and Pickles are prepared from the “tender green pods” of it. Are traditionally administered for their reported ability "to control blood sugar levels".7 This ethnobotanical record gives a direct link between the plant's fruit and its use in managing conditions associated with diabetes.
Despite this traditional application, a completely scientific understanding of the Radermachera xylocarpa fruit's antidiabetic potential remains broadly unexplored. Extensive academic literature searches for studies on the antidiabetic efficacy of Radermachera xylocarpa fruit extracts or detailed phytochemical analyses specifically concentrating on its pods have yielded limited direct results. While general ethnobotanical surveys affirm the part of medicinal plants in diabetes management.8 specific scientific examination into Radermachera xylocarpa fruit as an antidiabetic agent are notably absent. This highlights a important gap between traditional knowledge and modern scientific validation regarding this particular plant part. Previous research on Radermachera xylocarpa has primarily aimed on compounds from other parts, such as radermachol from the roots rather than the fruit's antidiabetic properties.9
Rationale and Significance of the Study:
The growing global prevalence of diabetes mellitus necessitates a continuous search for novel and effective therapeutic agents, with natural products offering a promising avenue for drug discovery. Traditional medicinal practices, particularly those linking plants, have historically served as a excellent source of therapeutic insights.10
In the context of Radermachera xylocarpa, traditional knowledge among indigenous communities specifically attributes blood sugar-controlling characteristics to pickles made from its "tender green pods". 7 This ethnobotanical information provides a compelling rationale for scientific examination. However, despite this traditional use, there is a distinct lack of modern scientific studies validating the antidiabetic ability of Radermachera xylocarpa fruit extract. Academic databases currently offer limited direct investigation on its antidiabetic mechanisms, bioactive compounds, or in vitro activity against key enzymes like alpha-amylase and alpha-glucosidase. While studies on other plants have demonstrated the potential of fruit extracts to forbidden these enzymes [this remains to be discovered for Radermachera xylocarpa fruit.11 This divergence between established traditional use and a scarcity of scientific evidence signifies a critical research gap that this study aims to bridge.
Radermachera xylocarpa:
Fig No. 2 Radermachera Xylocarpa Plant
Radermachera xylocarpa (Roxb.) is a lesser-known medicinal tree from the family Bignoniaceae, traditionally recognized for its diverse ethnomedicinal uses, consistings anti-inflammatory, antimicrobial, and antioxidant properties. and irrespective of its traditional relevance, limited scientific exploration has been conducted on its pharmacological potential, particularly regarding metabolic disorders such as diabetes mellitus. The fruit of R. xylocarpa is known to contain various phytoconstituents like flavonoids, alkaloids, terpenoids, and phenolic compounds—bioactive molecules that are frequently associated with antidiabetic and antioxidant mechanisms.
Given the global rise in diabetes prevalence and the limitations of current pharmacotherapies, investigating the antidiabetic potential of R. xylocarpa fruit extract represents a promising avenue for natural drug discovery. The present study aims to estimate its efficacy through biochemical investigations, focusing on in-vitro enzyme inhibition assays such as α-amylase inhibition, which is a well-established model for screening antidiabetic activity.
Radermachera xylocarpa, also known as the Padri tree, is a large deciduous tree native to India, found in dry deciduous forests. It is recognized for its distinctive lengthy, woody, and curved capsules, which can be up to 1 meter long and are sometimes called the “yellow snake tree”. The tree is also beneficial for its beautiful, fragrant, white to yellow flowers that appear in dense panicles, and it has various medicinal properties.
Table No. 1 Scientific classification
|
Kingdom: |
Plantae |
|
Clade: |
Tracheophytes |
|
Clade: |
Angiosperms |
|
Clade. |
Eudicots |
|
Order: |
Lamiales |
|
Family: |
Bignoniaceae |
|
Genus: |
Radermachera |
|
Species: |
R. xylocarpa |
|
Binomial name |
Radermachera xylocarpa (Roxb.) K. Schum. |
|
Synonyms |
Bignonia xylocarpa Roxb. Spathodea xylocarpa (Roxb.) T. Anderson ex Brand. Stereospermum xylocarpum (Roxb.) Benth. and Hook.f. Tecoma xylocarpa (Roxb.) G.Don |
Plant is effective for is antiseptic properties. Plant resin is commonly used for treating skin diseases root bark has astringent nature and bitter in taste. It is also called as yellow snake tree.R. Xylocarpa is reported to contain steroidal compound with higher concentration in different part of plant. leaves consist of flavonoid, dinatin and glycosides. The root of plant gives O-Acetyl olenic acid and stigmasterol. The tree has compound leaves and long dehiscent pods. The pods appear ‘snake’ like with irregular tubercles on the surface and has slightly curved apex. Consist of many seeds, winged light creamy yellow attached to hard cord like replum. In case of snake bite paste of seed is applied on bitten part also taken orally. The r. xylocarpa extract is used as antivenom.
Chemical Constituent:12
Table No. 2 Distribution of Phytochemical constituent in various part of radermachera xylocarpa
|
Sr. No. |
Compound Name |
Phytochemical Class |
Plant Part(s) |
|
1 |
1,2-Dihydropyrido(3,2,1-kl) phenothiazin-3-one |
Alkaloid |
Leaves |
|
2 |
7-Azaindole-3-carboxaldehyde |
Alkaloid |
Root |
|
3 |
β-Sitosterol |
Steroidal compound |
Leaves, Stem |
|
4 |
Cholesterol |
Steroidal compound |
Leaves |
|
5 |
Stigmast-4-en-3-one |
Steroidal compound |
Stem, Root |
|
6 |
Stigmasterol |
Steroidal compound |
Stem |
|
7 |
Cholest-4-en-one |
Steroidal compound |
Stem |
|
8 |
Ergosta-4,6,8(14),22-tetraen-3-one |
Steroidal compound |
Stem |
|
9 |
Squalene |
Terpenoid |
Stem |
Table No. 3 Comparative Profile of Compounds Identified in Leaf, Stem, and Root Dichloromethane Extracts of Radermachera xylocarpa
|
Sr. No. |
Compound Name |
Leaf (%) |
Stem (%) |
Root (%) |
|
1 |
Cyclopentanone, 2-(1-methylpropyl) |
0.310 |
– |
– |
|
2 |
Naphthalene |
2.210 |
– |
– |
|
3 |
Dibutyl phthalate |
19.930 |
3.950 |
5.330 |
|
4 |
1,2-Dihydropyrido(3,2,1-ki) Phenothiazin-3-one |
10.230 |
– |
– |
|
5 |
β-Sitosterol |
57.550 |
9.370 |
– |
|
6 |
Heptacosane |
3.080 |
4.510 |
– |
|
7 |
Tetracosane, 12-decyl-12-nonyl |
3.510 |
– |
– |
|
8 |
12-Hydroxyoctadecanethioic acid S-t-butyl ester |
3.010 |
– |
– |
|
9 |
Cholesterol |
0.130 |
– |
– |
|
10 |
Stigmast-4 E-one |
– |
4.520 |
– |
|
11 |
Stigmasterol |
– |
8.400 |
– |
|
12 |
Eicosane, 2-methyl- |
– |
2.350 |
– |
|
13 |
Cholest-4-en-one |
– |
60.550 |
– |
|
14 |
Ergosta-4,6,8(14),22-tetraen-3-one |
– |
3.150 |
– |
|
15 |
Heptacosane, 2,6,10,15-tetramethyl- |
– |
3.160 |
– |
|
16 |
Cyclopropane nomane |
– |
– |
1.470 |
|
17 |
Dodecane |
– |
– |
1.430 |
|
18 |
Tetradecane |
– |
– |
2.00 |
|
19 |
7-Azaindole-3-carboxaldehyde |
– |
– |
1.540 |
|
20 |
1-Hexadecane |
– |
– |
2.190 |
|
21 |
1-Nonadecane |
– |
– |
1.730 |
|
22 |
n-Hexadecanoic acid |
– |
– |
2.520 |
|
23 |
Stigmast-4-en-3-one |
– |
– |
28.280 |
|
24 |
Heptacosane |
– |
– |
5.400 |
|
25 |
Heptacosane (second isomer) |
– |
– |
7.820 |
|
26 |
Heptacosane (third isomer) |
– |
– |
12.030 |
|
27 |
Squalene |
– |
– |
12.970 |
|
28 |
Hentriaconate |
– |
– |
13.360 |
Pharmacological Activity:
1. Antioxidant Activity:
The plant Radermachera xylocarpa has gathered attention for its potential as a source of natural antioxidants, with studies highlighting the free radical scavenging activity of its methanolic stem and root bark extracts. This review synthesizes existing findings on the in vitro antioxidant efficacy of R. xylocarpa, examining its mechanisms and active compounds. Investigations into the methanolic extracts of R. xylocarpa stem and root bark have demonstrated momentous antioxidant activity across various in vitro free radical scavenging assays, indicating a dose-dependent response. Antioxidants act through various mechanisms, such as running as reducing agent, scavenging free radicals or quenching singlet oxygen. The methanolic extract of R. xylocarpa markedly exhibits a pronounced reducing property, likely attributed to its hydrogen-donating efficacy.
When compared to established antioxidants such as vitamin C, a well-known reducing agent, R. xylocarpa extracts showed moderate activity. This difference may stem from variations in their respective antioxidant mechanisms or disparities in their capacity to scavenge free radicals. Furthermore, as a crude extract, R. xylocarpa is expected to show a lower activity compared to pure compounds like vitamin C. 14
2. Anti-Lipid Peroxidative Effects:
Beyond direct radical scavenging, the root bark extract of R. xylocarpa has exhibited a significant anti-lipid peroxidative effect. Free radicals are occupied in the peroxidation of membrane lipids in vivo, with the secondary products contributing to the pathophysiology of numerous degenerative diseases. In the current study, the root bark extract effectively prohibited liver tissue lipid peroxidation induced by an Fe˛⁺/ascorbate system and mitigated hydrogen peroxide-mediated RBC lysis. Notably, the root bark extract displayed higher activity in these assays compared to both the stem bark extract and the standard vitamin C.
The experimental anti-lipid peroxidative effect is potentially linked to the root bark extract's radical-reducing properties. It is hypothesized that the extract can diminish free radicals responsible for membrane lipid peroxidation within the assay systems, and may also inhibit the generation of secondary radicals (lipid peroxide radicals) that preserve the peroxidative chain reaction.14
3. Antimicrobial Activity:
Radermachera xylocarpa has emerged as a promising natural source with demonstrable antimicrobial properties against a range of infective agents. This literature survey amalgamates the current understanding of the in vitro antimicrobial activity of R. xylocarpa extracts and its isolated compounds, particularly focusing on certain bacteria’s, fungi, and Herpes Simplex Virus type 1. To begin with investigations have provided the first in vitro evidence of antimicrobial activity of R. xylocarpethanolic extract against certain bacteria’s, fungi, and Herpes Simplex Virus type 1, all of which are directly related with various infectious diseases. The plant's major content of lapachol, an isolated compound from its stem bark, has led to a focus on both the crude ethanolic bark extract and isolated lapachol in studying their antimicrobial and anti-HSV-1 activities. While conclusion indicated that the highest concentrations of EE and lapachol exhibited moderate-to-poor antibacterial and antifungal activities when compared to control groups, their antiviral potential, particularly against HSV-1, warrants further attention.15-14
4. Antiviral Activity Against HSV-1:
Cytotoxicity studies exposed distinct CC50 (cytotoxic concentration 50%) and EC50 (effective concentration 50%) values for EE of R. xylocarpa and lapachol. Importantly, the activity against HSV-1 was detected to be lower than the CC50 dose, suggesting a favorable selectivity index. However, the antiviral efficacy of both EE and lapachol against HSV-1 was less pronounced compared to acyclovir, a widely used antiviral medication. Despite this, the evidence presented by EC50 values (40.2 µg cm⁻ł for EE and 2.5 µg cm⁻ł for lapachol) and corresponding SI (selectivity index) values (12.3 for EE and 33.2 for lapachol) highlights their potential. The study demonstrated that both crude EE and lapachol effectively prohibited HSV-1 infection in a dose-dependent manner, with 100% inhibition achieved at concentrations of 80 µg/ml for EE and 4 µg/ml for lapachol. Time-response assays further showed that both EE and lapachol interfere with the initial stages of HSV-1 replication, achieving maximal inhibition within 2–8 hours post-infection.17
MATERIALS AND METHODOLOGY:
Materials: R. xylocarpa fruit, Ethanol, Alpha amylase, Phosphate buffer, Acarbose, DNSA reagent, Dragendroff reagent, 1N NaOH, 1%FeCl3, 2%NaOH, Choroform, Conc Sulphuric acid.
Plant Material Collection and Authentication:
Collection of plant Material: The fruit of Radermachera xylocarpa was collected from its natural habitat that is from Sindhudurg, ensuring proper identification and authentication by a qualified botanist from Shri Pancham Khemraj Mahavidyalaya Sawantwadi. Subsequently, the collected plant material underwent meticulous processing, including thorough washing, drying to prepare it for solvent extraction and subsequent phytochemical analysis.
Preparation of Extract:
Drying of Plant Material: The collected fruits were then subjected to shade drying at ambient temperature to preserve their active constituents and prevent degradation. This drying process is important for reducing moisture content, thereby preventing microbial growth and enzymatic degradation that could alter the phytochemical profile of the extract. After drying, the fruits were ground into a fine powder using a mechanical grinder, increasing the surface area for optimal extraction of bioactive compounds. This fine powder was then stored in airtight containers at controlled temperature and humidity to maintain its chemical integrity until further use.
Extraction: The dried fruit material was then subjected to an alcoholic extraction process to obtain a crude extract, which was subsequently concentrated to yield the final extract for further experimentation maceration was performed by immersing the dried and powdered plant material in ethanol for 24hours at room temperature with intermittent shaking to maximize the yield of soluble phytochemicals. the ratio of dried plant material to solvent was maintained at 1:10 (w/v) to ensure efficient extraction. This process was repetitive three times with fresh solvent to ensure exhaustive extraction of the bioactive compounds. The resultant alcoholic extracts were then filtered through Whatman filter paper to eliminate particulate matter and subsequently concentrated at 40°C to yield a dark, viscous crude extract.16
Yield calculation: The percentage yield of the crude extract was determined by calculating the ratio of the weight of the dried extract to the initial weight of the powdered plant material. This quantitative measure is necessary for evaluating extraction efficiency and for standardizing subsequent experimental procedures.
Phytochemical Screening: The concentrated extract underwent preliminary phytochemical screening to identify the presence of major secondary metabolites such as alkaloids, flavonoids, tannins, saponins, and glycosides, which are often associated with antidiabetic activity. Qualitative tests provide an initial insight into the potential bioactivity of the Radermachera xylocarpa fruit extract, guiding further targeted investigations into its antidiabetic mechanisms. The presence of these compounds, particularly flavonoids, commonly indicates potential antioxidant and anti-inflammatory properties that can contribute to the overall antidiabetic effects by protecting pancreatic beta cells and improving insulin sensitivity Furthermore, a comprehensive understanding of the specific phytochemicals present in Radermachera xylocarpa is crucial, as individual compounds or synergistic combinations thereof could be responsible for the presence antidiabetic properties.18
Procedure for Phytochemical Screening:
1. Detection of alkaloids:
Take a few ml of filtrate + 1-2ml of dragendorff's reagent.
2. Detection of Napthaquinone:
Take 1ml of filtrate + 2-3 drops of 1N NaOH and shake well.
3. Detection of lapachol:
Take 1ml of extract solution add 1-2 drops of 1% ferric chloride solution and mix thoroughly.
4. Detection of isoquercitrin:
Take a few ml of extract + few drops of 2% NaOH.
5. Detection of Steroids:
Take 1ml of extract and dissolved in 10ml of chloroform + equal volume of sulphuric acid was added by the side of the test tube.
6. Detection of terpenoids:
Take 1ml of extract and dissolve in 0.4ml of chloroform + 0.6ml of concentrated sulphuric acid was added by the side of the test tube.
7. Detection of phenols:
Take a few ml of extract solution + 5% ferric chloride solution.18
In-vitro Antidiabetic Assays:
This comprehensive screening entitles a preliminary characterization of the extract's chemical profile, which is important for understanding its potential pharmacological actions. in vitro antidiabetic assay. The assessment of the extract's antidiabetic potential involved various in vitro assays, including α-glucosidase and α-amylase inhibition studies, which are critical for evaluating its ability to modulate carbohydrate digestion. These assays provide direct evidence of the extract's ability to interfere with key metabolic enzymes, thereby contributing insights into its potential for mitigating postprandial hyperglycemia. 19
α-amylase inhibition assay:
This assay is commonly employed to assess the potential of plant extracts to inhibit the activity of α-amylase, an enzyme crucial for breaking down complex carbohydrates into simpler sugars in the digestive tract By inhibiting α-amylase, the Radermachera xylocarpa extract could potentially decrease postprandial glucose levels, thereby offering a therapeutic approach for managing hyperglycemia in diabetic individuals. The α-amylase inhibition assay procedure involved incubating several concentrations of the extract with the enzyme and substrate, followed by spectrophotometric measurement of the product formed, enabling the discovery of the IC50 value, which indicates the concentration required for 50% enzyme inhibition. (Procedure)19
Procedure for Anti Diabetic Assay using Alpha Amyalse Method:
Preparation of DNSA solution: In a beaker 1 g of DNSA is dissolved in 20ml of ethanol, 30g of Sodium Potassium titrate is mixed well with 50ml water, above 50ml (2N) NaOH is prepared, in 20ml DNSA Solution 20ml (2N) NaOH Solution and sodium potassium titrate solution are followed with continuous stirring slowly to obtain clear solution, the mixture is filtered using filtered paper and volume is made up to 100ml with water.
Antidiabetic Assay: In Vitro amylase inhibition assay was calculated by the method of Bernfeld, Different concertation’s (20, 40, 60, 80, 100µg/ml) test and compound was reacted along with 500µL of 0.1M Phosphate buffer of pH 6.9 containing alpha amylase enzyme after 10min incubation at 25şC, 1% Starch Solution in 0.1M Phosphate buffer pH 6.8 was added again incubate at 25şc. The same procedure was carried out for the control 1000µl of DNSA Solution was added to both control and test, all the test tube were kept in boiling water for 10ml and cooled the absorbance was recorded as 540 nm using spectrophotometer and the percent inhibition of alpha amylase was calculated using formula-20
![]()
Fig No. 3 Images of Activity
RESULT:
Table No.4 -Yield Calculation:
|
Crude plant use for extraction (gm) |
Total yield obtain after extraction (gm) |
|
60.00 g |
1.7g |
Crude plant used (g)) 1.7
Yield (%)= --------------------------- x 100 = ---------------- x 100 = 2.83 %
Extract obtained (g) 60
Phytochemical Test:
Table No. 5- Result of Qualitative Phytochemical Analysis
|
Sr. No. |
Test |
Inferences |
|
1. |
Detection of alkaloid |
Alkaloid Present |
|
2. |
Detection of Naphthaquinone |
Naphaquinone Present |
|
3. |
Detection of lapachol |
Lapachol Present |
|
4. |
Detection of isoquercitrin |
Isoquercitrin Present |
|
5. |
Detection of steroids |
Steroids Present |
|
6. |
Detection of terpenoids |
Terpenoids Present |
|
7. |
Detection of phenols |
Phenol Present |
α-amylase inhibition assay:
The in-vitro α-amylase inhibition assay was conducted to evaluate the antidiabetic potential of the test sample (RXE1) and to compare it with the standard drug Acarbose. The absorbance of the reaction mixture was recorded at 540nm, and the percentage inhibition of the enzyme was calculated.
Table No. 6 Observation table of α-amylase enzyme inhibition assay
|
Sr. No. |
Sample |
Concentration (µg/mL) |
Mean Absorbance (540 nm) |
% Inhibition |
|
1 |
Control |
– |
1.74 |
– |
|
2 |
Standard (Acarbose) |
20 |
1.42 |
18.39% |
|
40 |
1.07 |
38.50% |
||
|
60 |
0.71 |
59.19% |
||
|
80 |
0.50 |
71.26% |
||
|
100 |
0.27 |
84.48% |
||
|
3 |
Test (RXE1) |
20 |
1.46 |
16.09% |
|
40 |
1.24 |
28.73% |
||
|
60 |
1.12 |
35.63% |
||
|
80 |
0.94 |
45.97% |
||
|
100 |
0.74 |
57.47% |
Fig No. 4 Graphical data
DISCUSSION AND CONCLUSION:
The in-vitro α-amylase inhibition model is a well-established method for screening potential antidiabetic agents that function by delaying carbohydrate digestion and glucose absorption. In this study, the standard drug Acarbose exhibited maximum inhibition of 84.48% at 100 µg/mL, whereas the test extract RXE1 showed 57.47% inhibition at the same concentration.
The inhibition increased progressively from 16.09% at 20 µg/mL to 57.47% at 100 µg/mL, suggesting that the extract possesses moderate α-amylase inhibitory activity in a dose-dependent manner. This trend indicates the possible presence of bioactive phytoconstituents such as, phenolic compounds, and terpenoids, which are known for their ability to modulate digestive enzyme activity and enhance postprandial glucose regulation.
Phytochemical screening confirmed the presence of phenols, alkaloids, terpenoids, steroids, isoquercitrin, lapachol, and naphthaquinones, many of which are known for antidiabetic, antioxidant, and enzyme-inhibition properties. These compounds may act synergistically suppress starch breakdown, thus supporting the observed biological activity.
The study states that the test extract RXE1 exhibits dose-dependent α-amylase inhibitory activity, confirming its potential as a moderate in-vitro antidiabetic agent. Although its inhibitory effect is lower than that of Acarbose, the results suggest that the extract contains bioactive compounds capable of reducing enzymatic breakdown of starch into glucose, thereby helping in the control of postprandial hyperglycemia.
Overall, the findings suggest that R. xylocarpa fruit contains bioactive molecules capable of moderating carbohydrate metabolism, which aligns with its traditional use for controlling blood sugar levels among local tribal communities.
ACKNOWLEDGEMENTS:
The authors express their sincere gratitude to Shree Pushpasen Sawant College of Pharmacy, Digas, for providing the necessary infrastructure and academic support to carry out this research work. We are also thankful to the laboratory staff for their continuous assistance, technical support, and cooperation throughout the experimental work. Their contributions were invaluable to the successful completion of this study.
REFERENCES:
1. Saha P, Kumar R, Sahana S, Kumar Y, Dubey A, Prakash O. A review on diabetes mellitus: Type 1 and Type 2. World Journal of Pharmacy and Pharmaceutical Sciences. 2020 Oct;9(10):838–850
2. Bastaki. s Diabetes mellitus and it’s treatment. Int J Diabetes and Metabolism. 2005;13(3):111-134.
3. Mehta SR, Kashyap AS, Das S. Diabetes Mellitus in India: The Modern Scourge. Med J Armed Forces India. 2009; 65(1): 50–54.
5. Deshmukh CD, Jain A. Diabetes Mellitus: A Review. Int J Pure App Biosci. 2015; 3(3): 224-230.
6. Jacob B, Narendhirakannan RT. Role of medicinal plants in the management of diabetes mellitus: a review. Biotech. 2019; 9(4): 1-17.
7. Sathe, M., Vibhute, M., Jain, M., and Srivastav, P. A Novel Method for Efficient Micropropagation of Radermachera xylocarpa (Roxb.) K. Schum., a Rare Medicinally Important Forest Species. Plant Tissue Culture and Biotechnology. 2013; 23(1): 21?29. https://doi.org/10.3329/ptcb.v23i1.15556
8. Gurav, Kolhe, Goli, Rath, Mangal, Srikanth, Exploration of Traditional Pickle Recipes Prepared by Tribal of Jawhar and Shahapur Forest Divisions Journal of Drug Research in Ayurvedic Sciences. 2019
9. Rahman, M.M.; Uddin, M.J.; Reza, A.S.M.A.; Tareq, A.M.; Emran, T.B.; Simal-Gandara, J. Ethnomedicinal Value of Antidiabetic Plants in Bangladesh: A Comprehensive Review. Plants. 2021; 10: 729. https://doi.org/10.3390/plants10040729
10. Balawant S. Joshi, Dilip H. Gawad, S. William Pelletier, Gopinath Kartha, Krishna Bhandary, The structure of radermachol, an unusual pigment from Radermachera xylocarpa K. Schum., Tetrahedron Letters. 1984; 25(51): 5847-5850, https://doi.org/10.1016/S0040-4039(01)81701-9
11. Ansari, P.; Samia, J.F.; Khan, J.T.; Rafi, M.R.; Rahman, M.S.; Rahman, A.B.; Abdel-Wahab, Y.H.A.; Seidel, V. Protective Effects of Medicinal Plant-Based Foods against Diabetes: A Review on Pharmacology, Phytochemistry, and Molecular Mechanisms. Nutrients 2023; 15: 3266. https://doi.org/10.3390/nu15143266
12. Wargiary, A., Daimari, M. Identification of bioactive compounds by GC-MS and α-amylase and α-glucosidase inhibitory activity of Rauvolfia tetraphylla L. and Oroxylum indicum (L.) Kurz: an in vitro and in silico approach. Clin Phytosci. 2020; 6: 75. https://doi.org/10.1186/s40816-020-00219-3
13. Ekade PP, Manik SR. Investigations on secondary metabolites in different parts of Radermachera xylocarpa using GC-MS. J Pharmacogn Phytochem. 2014; 2(6): 39–47.
14. Kalaskar S, Harisha CR, Patel BR, Shukla VJ. Comparative pharmacognostical and analytical studies of stem barks of species Stereospermum suaveolens (Roxb.) DC and Radermachera xylocarpa (Roxb.) K. Schum. Universal Journal of Pharmacy. 2014; 3(6): 39–45.
15. Salini S, chubicka T, Raghavamenon AC, Babu TD. Evaluation of antioxidant activities of Radermachera xylocarpa K. Schum. Int J PharmTech Res. 2014; 6(2): 704-709.
16. Sukumar D, Anandhi B. Antibacterial studies on the isolates of Radermachera xylocarpa. Int J Sci Res. 2014; 3(4): 64–65.
17. Shetgiri NP, Kokitkar SV, Sawant SN. Radermachera xylocarpa: the highly efficient source of lapachol and synthesis of its derivatives. Acta Pol Pharm Drug Res. 2001; 58(2): 133-135.
18. Paul RK, Sengupta S, Roy D, Sarkar D, Biswas S, Dasgupta D, Mariappan G, Alam F, Nag M. Antibacterial, anti-fungal, and anti-HSV-1 activity of isolated compound lapachol from Radermachera xylocarpa stem bark. 1
19. Ezeonu CS, Ejikeme CM. Qualitative and quantitative determination of phytochemical contents of indigenous Nigerian softwoods. New J Sci. 2016; 2016: 1–9
20. Tamil IG, Dineshkumar B, Nandhakumar M, Senthilkumar M, Mitra A. In vitro study on α-amylase inhibitory activity of an Indian medicinal plant, Phyllanthus amarus. Indian J Pharmacol. 2010; 42(5): 280–282. doi:10.4103/0253-7613.70107
21. Wickramaratne MN, Punchihewa JC, Wickramaratne DBM. In-vitro α-amylase inhibitory activity of the leaf extracts of Adenanthera pavonina. Biomed Res Int. 2016; 2016:1–7.
|
Received on 18.11.2025 Revised on 05.03.2026 Accepted on 13.05.2026 Published on 15.10.2026 Available online from October 26, 2026 Res. J. Pharmacognosy and Phytochem. 2026; 18(4):336-344. DOI: 10.52711/0975-4385.2026.00048 ©AandV Publications All right reserved
|
|
|
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License. |
|